Frontline Season 18 Episode 12 Dr Solomon's Dilemma

Dr Solomon's Dilemma is the 12th episode of the 18th season of Frontline. In this episode, the show investigates the controversy surrounding the use of a particular drug called Ketek, which was approved by the FDA in 2004 for the treatment of respiratory tract infections. The drug was manufactured by Sanofi-Aventis, a French pharmaceutical company.

The episode showcases the story of Dr. Anne-Marie Cavanaugh, a clinical investigator who conducted a clinical trial of Ketek in her private practice in Texas. She noticed several adverse effects in patients who took the drug, including liver failure, blurred vision, and loss of consciousness. Despite her concerns, the drug was approved by the FDA, and Sanofi-Aventis marketed it aggressively to doctors across the United States.

As the episode unfolds, Frontline traces the journey of Dr. Cavanaugh as she tries to raise awareness about the dangers of Ketek. Her efforts are met with resistance from Sanofi-Aventis, who deny any wrongdoing and continue to push the drug in the market. Dr. Cavanaugh also faces opposition from her own medical community, who are hesitant to speak out against a drug that has been approved by the FDA.

Frontline also interviews other doctors, patients, and families who have been affected by Ketek. Some have suffered severe liver damage, and others have lost their loved ones to the drug. The show delves into the various factors that contributed to the approval and marketing of Ketek, including the FDA's fast-track approval process, the influence of lobbying groups, and the financial interests of pharmaceutical companies.

The episode raises important questions about the ways in which drugs are approved and marketed in the United States. It highlights the risks and consequences of fast-tracking drugs without adequate testing and the importance of holding pharmaceutical companies accountable for their actions. The show also sheds light on the challenges that medical professionals face when trying to speak out against a powerful industry.

Overall, Dr. Solomon's Dilemma is a thought-provoking and compelling episode that delves into a significant public health concern. It showcases the power of investigative journalism in highlighting crucial issues and inspiring change.